Denali Therapeutics Inc. (DNLI) /
The debt of Denali Therapeutics Inc. over the past 10 years
Chart Denali Therapeutics Inc.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Denali Therapeutics Inc. had liquid cash of $867.88M and total debt of $0: net cash of $867.88M. It had more liquid cash than debt at all 9 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $867.88M* | $0 | $867.88M |
| 2024ended Dec 31, 2024 | $832.33M* | $0 | $832.33M |
| 2023ended Dec 31, 2023 | $1.03B* | $0 | $1.03B |
| 2022ended Dec 31, 2022 | $1.34B* | $0 | $1.34B |
| 2021ended Dec 31, 2021 | $865.41M* | $0 | $865.41M |
| 2020ended Dec 31, 2020 | $1.47B* | $0 | $1.47B |
| 2019ended Dec 31, 2019 | $415.36M* | $0 | $415.36M |
| 2018ended Dec 31, 2018 | $464.3M* | $0 | $464.3M |
| 2017ended Dec 31, 2017 | $406.23M* | $0 | $406.23M |
| 2016ended Dec 31, 2016 | — | — | — |
Fiscal years as Denali Therapeutics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Denali Therapeutics Inc.
- The revenue of Denali Therapeutics Inc.
- The profitability of Denali Therapeutics Inc.
- The cash flow of Denali Therapeutics Inc.
- All of Denali Therapeutics Inc.'s financials, charted
Companies of a similar size
- STEPSTEPSTONE GROUP INC.
- GNWGENWORTH FINANCIAL, INC.
- TNKTEEKAY TANKERS LTD.
- COCOThe Vita Coco Company, Inc.
- LMNDLemonade, Inc.
Not investment advice. This page shows what Denali Therapeutics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.